Eisler Capital »

Regeneron Pharmaceuticals shares owned by Eisler Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Eisler Capital from 13F filings

Historical chart of Eisler Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Eisler Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Eisler Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 1.5k 823.24
2022-03-31 $19M 28k 698.40
2021-12-31 $12M 18k 631.77

More positions owned by Eisler Capital

Wells Fargo & Company Call Option (WFC)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Metropcs Communications (TMUS)
Amazon (AMZN)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Tesla Motors Call Option (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Citigroup Com New Call Option (C)
Lam Research Corporation Call Option (LRCX)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Eisler Capital

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals